Home Infusions Solutions, Inc.
FDA inspection history in Horsham, Pennsylvania, 2013 to 2014
- 1
- Response
- 1
- Form 483
Every document, by year
- Response
- Form 483
2013: one Form 483; 2014: one 483 response.
The story so far
Built from the dates and citations on the documents themselves.
- 2013–14One Form 483 and one 483 response, at Horsham, Pennsylvania.
Cited most
Across all Home Infusions Solutions observations on file
- 21 CFR 211.42(a)Design and construction features2
- 21 CFR 211.113(b)Control of microbiological contamination1
- 21 CFR 211.166(a)Stability testing1
- 21 CFR 211.28(a)Personnel responsibilities1
The complete Home Infusions Solutions file.
All 2 documents as original PDFs, in one order. For supplier audits, diligence and inspection prep.
The price of the documents, added to your cart together
Sites
Horsham, Pennsylvania
One 483 response and one Form 483 · 2013 to 2014 · 5 observations
Latest: Response, Mar 27, 2014 →
Documents
2 on file, newest first| Date | Document | Location | Observations | Price |
|---|---|---|---|---|
| 2014-03-27 | Response 483 response | Horsham, Pennsylvania | — | $199 |
| 2013-05-21 | 483 Form 483 | Horsham, Pennsylvania | 5 | $99 |
Investigators on these documents
FEI number 3009803574 · most recent document Mar 27, 2014
About Home Infusions Solutions, Inc.
How many FDA Form 483s has Home Infusions Solutions, Inc. received?
FDA Intel has 1 Form 483 on file for Home Infusions Solutions, Inc.; the most recent is dated May 21, 2013.
When was Home Infusions Solutions, Inc. last inspected by FDA?
The most recent FDA inspection document on file for Home Infusions Solutions, Inc. is a Form 483 dated May 21, 2013, for the site in Horsham, Pennsylvania.
What did FDA cite at Home Infusions Solutions, Inc.?
The regulations cited most in the observations on file for Home Infusions Solutions, Inc. are 21 CFR 211.42(a) (Design and construction features), 2 times; 21 CFR 211.113(b) (Control of microbiological contamination), 1 time; 21 CFR 211.166(a) (Stability testing), 1 time.